adicetbio.com (ACET) Company Sales Volume
Adicet Bio's business is resilient to market volatility, as demand for cancer treatment remains stable. This chart from the GURU.Markets terminal illustrates the company's product realization, where the value holds at 0.00. Production relies on robotic bioreactors and AI-driven sterility control. The environmental footprint is minimal due to strict adherence to medical regulations regarding biomaterial disposal.
Comprehensive metric breakdowns and analytics for Adicet Bio Inc. (ACET)
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
- business earnings and investment ratios data:
ACET - Net Income|Expected Net Income Adicet Bio|ACET - P/E Multiple|Future Price to Earnings Adicet|ACET - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Adicet Bio, Inc.|ACET - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Adicet Bio|ACET - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth adicetbio.com|ACET - Earnings growth in current year|Expected earnings per share growth for next year Adicet Bio
- company sales and revenue statistics:
Summary company analysis:ACET adicetbio.com
Sales record the actual volume of products sold, excluding accounting adjustments to assess real consumer demand. By analyzing the corporate sales dynamics of Adicet Bio (ACET), an investor can gauge the efficiency of monetizing developments amid the hiring of high-cost sterile manufacturing specialists. The stability of this flow determines the company's ability to retain its core team of researchers. This indicator serves as a fundamental filter for asset resilience during market downturns.
Key competitors
Revenue and Sales Volume argenx BVBA|Company Revenue BioNTech SE (BNTX)|Abivax SA - Company Sales Volume|Revenue and Sales Volume ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Company Total Revenue|Immunovant Corp - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|GRFS: Revenue and Sales Volume|Company Sales Volume ADPT|CLDX (Celldex Therapeutics, Inc.) - Revenue and Sales Volume|Aurinia Pharmaceuticals Inc (AUPH) - Company Gross Revenue|Revenue and Sales Volume BCRX|Company Sales Vera Corp VERA|Revenue and Sales Volume DNTH (Dianthus Therapeutics)|pharvaris.com (PHVS) - Company Total Revenue|ABCL: Company Sales|Tourmaline Bio Inc - Company Total Sales|PGEN (Intrexon) - Company Sales|Pharming Corp - Company Sales Revenue|NKTR (Nektar Therapeutics) - Revenue and Sales Volume|Company Revenue UPB|Revenue and Sales Volume ZBIO|Company Gross Revenue Immunome Inc|Company Revenue Gossamer Corp GOSS|KalVista Corp (KALV) - Company Total Revenue|Septerna Inc - Revenue and Sales Volume|PVLA - Revenue and Sales Volume|SVRA: Revenue and Sales Volume|Company Sales Rigel Pharma|ANAB (AnaptysBio Corp) - Revenue and Sales Volume|Company Total Revenue Astria Corp ATXS|Company Sales ENGN (enGene Holdings Inc.)|Company Total Sales RAPT|Company Revenue Aerovate Therapeutics JBIO|ACRS (Aclaris Therapeutics Inc.) - Company Annual Revenue|Kyverna - Revenue and Sales Volume|Company Sales Revenue TLSA (Tiziana Life Sciences, Ltd.)|CABA: Revenue and Sales Volume|ventyxbio.com (VTYX) - Revenue and Sales Volume|Company Revenue Theratechnologies|AVTX: Company Sales Revenue|Company Revenue Eledon (ELDN)|Company Sales Agenus, Inc AGEN|Revenue and Sales Volume CLYM (Climb Bio Inc)|Revenue and Sales Volume zurabio.com ZURA|ATYR: Company Sales|Company Sales Revenue ADAG (Adagene)|IMA: Revenue and Sales Volume|STTK - Company Gross Revenue|Company Revenue Equillium Inc|Company Sales Connect Pharma (CNTB)|Company Revenue Immunic, Inc. (IMUX)|Company Sales atarabio.com ATRA|InflaRx - Company Sales|Revenue and Sales Volume X4 Pharmaceuticals, Inc XFOR|CELU - Company Revenue|INMB (inmunebio.com) - Company Sales Volume|BRNS: Revenue and Sales Volume|Company Total Revenue Kezar Life Sciences Inc. (KZR)|SABS (SAB Biotherapeutics, Inc) - Revenue and Sales Volume|Revenue and Sales Volume Akari Therapeutics, Plc|Revenue and Sales Volume ENLV|q32bio.com - Company Sales Volume|Revenue and Sales Volume GOVX (GeoVax)|Company Gross Revenue Edesa Biotech Inc (EDSA)|iBio Corp - Revenue and Sales Volume|Carisma Therapeutics (CARM) - Company Sales|XTLB: Revenue and Sales Volume|Company Total Revenue Bolt Biotherapeutics, Inc. (BOLT)|Company Sales HCWB|APVO (Aptevo) - Company Total Sales|Company Sales AIM (AIM ImmunoTech)|ADTX (aditxt.com) - Company Sales Revenue|Revenue and Sales Volume GRI (GRI Bio, Inc.)|xortx.com - Company Revenue|Vyome Holdings - Revenue and Sales Volume|Company Gross Revenue Revelation Biosciences Inc REVB|Indaptus (INDP) - Company Revenue|Company Total Revenue BiondVax Pharmaceuticals (SCNI)|CALI (CalciMedica Inc) - Revenue and Sales Volume|Revenue and Sales Volume Affimed Therapeutics|Revenue and Sales Volume ALLK|Company Sales hookipapharma.com HOOK|Revenue and Sales Volume IGMS (IGM Biosciences)|iTeos Pharma (ITOS) - Company Total Revenue|OCEA: Company Sales|tcbiopharm.com - Company Total Sales|Third Harmonic Bio, Inc. (THRD) - Company Revenue
